In contrast, staining with the lymphatic vessel marker Podoplanin showed an opposite pattern with an increased number of peritumoral lymphatic vessels in the ER−tumors, suggesting that NCoR might also inhibit lymphangiogenesis in human breast tumors. This evidence concerns the gene NCOR1 and breast neoplasm.